Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
Abroad (travel likely)Recruiting
Conditions
Biliary Tract Cancer · Cholangiocarcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Bundang CHA Medical Center, Seongnam-si, Gyeonggi-do, South Korea
Study leads
Hong Jae Chon, MD. PhD
Principal Investigator
CHA University